Opinion|Videos|August 30, 2024
Strategies to Manage Type 2 Inflammation in Respiratory Diseases
Author(s)Reynold A. Panettieri Jr, MD
A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.
Advertisement
Episodes in this series
- How do these markers influence the treatment regimen for patients with asthma or COPD?
- How do comorbidities affect the management of type 2 inflammation in asthma and COPD?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show
2
COPERNICOS Trial: Eosinophil-Guided ICS Reduction Safe in COPD, Vestbo Says
3
Primary Care Capacity Gaps Threaten Respiratory Prevention
4
COPD Deaths Rival Heart Failure, Exceed Prostate and Breast Cancer
5